Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Alphamab Oncology has dosed the first subject in the randomised Phase III JSKN003-306 trial of its anti-human epidermal ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

A local radio host is encouraging Tucsonans to consider genetic testing after it played a critical role in her own health ...

LONDON - GENinCode PLC (AIM:GENI.L), a company specializing in the prevention of cardiovascular disease and the early detection of ovarian cancer, has announced a retail offer of new Ordinary Shares ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.